Use of Data Monitoring Committees in Clinical Trials
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 13, 2024
February 13, 2024
9d0ee35d-4fcc-4c44-88ac-f56c6a60187b
Related Documents
Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry
Guidance DocumentJanuary 9, 2026Center for Drug Evaluation and Research
Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices
Guidance DocumentDecember 30, 2024Center for Drug Evaluation and Research
Considerations for Rescinding Breakthrough Therapy Designation
Guidance DocumentJune 24, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.